Detalhe da pesquisa
1.
Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trial.
Int J Cancer
; 153(6): 1241-1250, 2023 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37294085
2.
Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b study.
Lancet Oncol
; 23(11): 1398-1408, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-36265504
3.
Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases.
World J Urol
; 38(8): 1959-1968, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-31691084
4.
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 20(3): 408-419, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30738780
5.
Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial.
Lancet Oncol
; 18(11): 1532-1542, 2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-29033099
6.
The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma.
Hum Mol Genet
; 21(5): 1190-200, 2012 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-22113997
7.
Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors.
PLoS Genet
; 7(10): e1002312, 2011 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-22022277
8.
Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial.
Lancet Oncol
; 14(8): 760-8, 2013 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-23742877
9.
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial.
Lancet Oncol
; 14(13): 1307-16, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-24211163
10.
An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies.
Int J Cancer
; 132(11): 2640-7, 2013 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23150424
11.
Smoking Cessation After Diagnosis of Kidney Cancer Is Associated With Reduced Risk of Mortality and Cancer Progression: A Prospective Cohort Study.
J Clin Oncol
; 41(15): 2747-2755, 2023 05 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36989465
12.
[Importance of HPV status and p16 for the prognosis of penile carcinoma]. / Bedeutung von HPV-Status und p16 für die Prognose des Peniskarzinoms.
Aktuelle Urol
; 54(4): 274-284, 2023 08.
Artigo
Alemão
| MEDLINE | ID: mdl-37541236
13.
Evaluation of Prognostic Parameters to Identify Aggressive Penile Carcinomas.
Cancers (Basel)
; 15(19)2023 Sep 27.
Artigo
Inglês
| MEDLINE | ID: mdl-37835442
14.
Primary Extranodal Marginal Zone Lymphoma of the Renal Pelvis: A Case Report and Review of the Literature.
Case Rep Oncol
; 15(1): 362-368, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35529296
15.
Accounting for B-cell Behavior and Sampling Bias Predicts Anti-PD-L1 Response in Bladder Cancer.
Cancer Immunol Res
; 10(3): 343-353, 2022 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35013004
16.
The prominent role of the S100A8/S100A9-CD147 axis in the progression of penile cancer.
Front Oncol
; 12: 891511, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36303837
17.
DKK1 inhibits canonical Wnt signaling in human papillomavirus-positive penile cancer cells.
Transl Oncol
; 15(1): 101267, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34773828
18.
Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells.
Carcinogenesis
; 32(12): 1773-81, 2011 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-21940908
19.
Occupational exposure to arsenic, cadmium, chromium, lead and nickel, and renal cell carcinoma: a case-control study from Central and Eastern Europe.
Occup Environ Med
; 68(10): 723-8, 2011 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-21217163
20.
The Choice of Candidates in Survival Markers Based on Coordinated Gene Expression in Renal Cancer.
Front Oncol
; 11: 615787, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34046336